Drug Profile
Research programme: Japanese encephalitis vaccine - Sinovac Biotech
Alternative Names: Inactivated JEV vaccine - Sinovac BiotechLatest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Sinovac Biotech
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Encephalitis virus infections
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Encephalitis-virus-infections(Prevention) in China (Parenteral, Injection)
- 18 Sep 2008 Preclinical development is ongoing in China
- 18 Jul 2006 Preclinical trials in Encephalitis virus infections in China (Parenteral)